185 related articles for article (PubMed ID: 11733975)
1. Risk factors for epithelial borderline ovarian tumors: results of a Swedish case-control study.
Riman T; Dickman PW; Nilsson S; Correia N; Nordlinder H; Magnusson CM; Persson IR
Gynecol Oncol; 2001 Dec; 83(3):575-85. PubMed ID: 11733975
[TBL] [Abstract][Full Text] [Related]
2. Case-control study of borderline ovarian tumors: reproductive history and exposure to exogenous female hormones.
Harlow BL; Weiss NS; Roth GJ; Chu J; Daling JR
Cancer Res; 1988 Oct; 48(20):5849-52. PubMed ID: 3167840
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for ovarian cancer in central Italy.
Greggi S; Parazzini F; Paratore MP; Chatenoud L; Legge F; Mancuso S; La Vecchia C
Gynecol Oncol; 2000 Oct; 79(1):50-4. PubMed ID: 11006030
[TBL] [Abstract][Full Text] [Related]
4. Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer.
Slattery ML; Potter JD; Curtin K; Edwards S; Ma KN; Anderson K; Schaffer D; Samowitz WS
Cancer Res; 2001 Jan; 61(1):126-30. PubMed ID: 11196149
[TBL] [Abstract][Full Text] [Related]
5. Oral contraceptive use and risk of colorectal cancer.
Fernandez E; La Vecchia C; Franceschi S; Braga C; Talamini R; Negri E; Parazzini F
Epidemiology; 1998 May; 9(3):295-300. PubMed ID: 9583422
[TBL] [Abstract][Full Text] [Related]
6. Hormone replacement therapy and risk of epithelial ovarian cancer.
Purdie DM; Bain CJ; Siskind V; Russell P; Hacker NF; Ward BG; Quinn MA; Green AC
Br J Cancer; 1999 Oct; 81(3):559-63. PubMed ID: 10507786
[TBL] [Abstract][Full Text] [Related]
7. Oral contraceptives and epithelial ovarian cancer. Does dose matter?
Sanderson M; Williams MA; Weiss NS; Hendrix NW; Chauhan SP
J Reprod Med; 2000 Sep; 45(9):720-6. PubMed ID: 11027080
[TBL] [Abstract][Full Text] [Related]
8. Reproductive factors of ovarian and endometrial cancer risk in a high fertility population in Mexico.
Salazar-Martinez E; Lazcano-Ponce EC; Gonzalez Lira-Lira G; Escudero-De los Rios P; Salmeron-Castro J; Hernandez-Avila M
Cancer Res; 1999 Aug; 59(15):3658-62. PubMed ID: 10446978
[TBL] [Abstract][Full Text] [Related]
9. Reproductive history and cigarette smoking as risk factors for thyroid cancer in women: a population-based case-control study.
Galanti MR; Hansson L; Lund E; Bergström R; Grimelius L; Stalsberg H; Carlsen E; Baron JA; Persson I; Ekbom A
Cancer Epidemiol Biomarkers Prev; 1996 Jun; 5(6):425-31. PubMed ID: 8781737
[TBL] [Abstract][Full Text] [Related]
10. Pelvic inflammatory disease and the risk of epithelial ovarian cancer.
Risch HA; Howe GR
Cancer Epidemiol Biomarkers Prev; 1995; 4(5):447-51. PubMed ID: 7549798
[TBL] [Abstract][Full Text] [Related]
11. Aspirin and epithelial ovarian cancer.
Akhmedkhanov A; Toniolo P; Zeleniuch-Jacquotte A; Kato I; Koenig KL; Shore RE
Prev Med; 2001 Dec; 33(6):682-7. PubMed ID: 11716667
[TBL] [Abstract][Full Text] [Related]
12. Estrogen replacement therapy and risk of epithelial ovarian cancer.
Risch HA
Gynecol Oncol; 1996 Nov; 63(2):254-7. PubMed ID: 8910636
[TBL] [Abstract][Full Text] [Related]
13. Reduced risk of ovarian cancer in women with a tubal ligation or hysterectomy. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives.
Rosenblatt KA; Thomas DB
Cancer Epidemiol Biomarkers Prev; 1996 Nov; 5(11):933-5. PubMed ID: 8922304
[TBL] [Abstract][Full Text] [Related]
14. Hormonal and reproductive risk factors for development of systemic lupus erythematosus: results of a population-based, case-control study.
Cooper GS; Dooley MA; Treadwell EL; St Clair EW; Gilkeson GS
Arthritis Rheum; 2002 Jul; 46(7):1830-9. PubMed ID: 12124867
[TBL] [Abstract][Full Text] [Related]
15. Population-based case-control study of ovarian cancer in Shanghai.
Shu XO; Brinton LA; Gao YT; Yuan JM
Cancer Res; 1989 Jul; 49(13):3670-4. PubMed ID: 2731180
[TBL] [Abstract][Full Text] [Related]
16. Differences in risk factors for epithelial ovarian cancer by histologic type. Results of a case-control study.
Risch HA; Marrett LD; Jain M; Howe GR
Am J Epidemiol; 1996 Aug; 144(4):363-72. PubMed ID: 8712193
[TBL] [Abstract][Full Text] [Related]
17. Psychotropic medication use and risk of epithelial ovarian cancer.
Harlow BL; Cramer DW; Baron JA; Titus-Ernstoff L; Greenberg ER
Cancer Epidemiol Biomarkers Prev; 1998 Aug; 7(8):697-702. PubMed ID: 9718222
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for epithelial ovarian tumours of borderline malignancy.
Parazzini F; Restelli C; La Vecchia C; Negri E; Chiari S; Maggi R; Mangioni C
Int J Epidemiol; 1991 Dec; 20(4):871-7. PubMed ID: 1800425
[TBL] [Abstract][Full Text] [Related]
19. Reproductive risk factors for mucinous and non-mucinous epithelial ovarian cancer.
Wittenberg J; Cook LS; Rossing MA; Weiss NS
Epidemiology; 1999 Nov; 10(6):761-3. PubMed ID: 10535792
[TBL] [Abstract][Full Text] [Related]
20. Reproductive history, use of exogenous hormones, and risk of colorectal adenomas.
Peipins LA; Newman B; Sandler RS
Cancer Epidemiol Biomarkers Prev; 1997 Sep; 6(9):671-5. PubMed ID: 9298573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
